Our research is translational, epidemiological, and patient-reported.

We are focused on:

  • Investigating the risks and outcomes of current cancer treatments in pre- and post-transplant patients, including for self-reported racial and ethnic minority solid organ transplant recipients.
  • Studying patient-reported health conditions and whether specific cancer and transplant outcomes in solid organ transplant recipients are associated with structural and individual racism and social determinants of health (access to healthcare, economic stability, access to education, social and community support).
  • Understanding patient- and caregiver-reported experiences with cancer and organ transplant to improve clinical care.
  • Leading translational research (research that can be applied in clinical care) to improve diagnostic tests and therapies.